Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-072754

Chief Financial Officer sold 1,920 shares at $8.50 ($16,320)

From the SEC's structured data for this filing

Trades in this filing

Trigilio Jeffrey · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-21 Sale : show line 1 in the form −1,920 $8.50 $16,320 83,919 D
Open-market sales · 1,920 sh · avg $8.50 · $16,320
Loading xslF345X05/ownership.xml…